NPPB and COVID-19: A complete diagnosis of HF usually includes symptoms, signs, biomarkers (BNP/NT-proBNP), and imaging examinations, while it is impractical and unavailable to evaluate cardiac function by echocardiography for each critically ill patient with COVID-19 in the clinical practice.